231 related articles for article (PubMed ID: 29173977)
1. [European guidelines (ESMO-ESGO-ESTRO consensus conference) for the management of endometrial cancer].
Ballester M; Bendifallah S; Daraï E
Bull Cancer; 2017 Dec; 104(12):1032-1038. PubMed ID: 29173977
[TBL] [Abstract][Full Text] [Related]
2. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.
Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M;
Ann Surg Oncol; 2017 Jun; 24(6):1660-1666. PubMed ID: 28058558
[TBL] [Abstract][Full Text] [Related]
3. The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study.
Buda A; Restaino S; Di Martino G; De Ponti E; Monterossi G; Dinoi G; Magni S; Quagliozzi L; Dell'Orto F; Ciccarone F; Lamanna M; Scambia G; Landoni F; Fanfani F
Eur J Surg Oncol; 2018 Oct; 44(10):1562-1567. PubMed ID: 30077521
[TBL] [Abstract][Full Text] [Related]
4. Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical staging.
Gultekin M; Guler OC; Yuce Sari S; Akkus Yildirim B; Onal C; Celik H; Yuce K; Ayhan A; Arik Z; Kose F; Altundag O; Zoto Mustafayev T; Atalar B; Bolukbasi Y; Yildiz F
J Obstet Gynaecol; 2021 Apr; 41(3):414-420. PubMed ID: 32347768
[TBL] [Abstract][Full Text] [Related]
5. Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group.
Bendifallah S; Ouldamer L; Lavoue V; Canlorbe G; Raimond E; Coutant C; Graesslin O; Touboul C; Collinet P; Daraï E; Ballester M;
Gynecol Oncol; 2017 Jan; 144(1):107-112. PubMed ID: 27789083
[TBL] [Abstract][Full Text] [Related]
6. High risk endometrial cancer: Clues towards a revision of the therapeutic paradigm.
Bendifallah S; Ilenko A; Daraï E
J Gynecol Obstet Hum Reprod; 2019 Dec; 48(10):863-871. PubMed ID: 31176047
[TBL] [Abstract][Full Text] [Related]
7. Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study.
Daraï E; Dubernard G; Bats AS; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Ballester M
Gynecol Oncol; 2015 Jan; 136(1):54-9. PubMed ID: 25450151
[TBL] [Abstract][Full Text] [Related]
8. [What's new in the management of endometrial cancer? Update on the new European recommendations for 2021].
Azaïs H; Lecointre L; Canlorbe G;
Gynecol Obstet Fertil Senol; 2021 Sep; 49(9):691-697. PubMed ID: 33757927
[TBL] [Abstract][Full Text] [Related]
9. Endometrial cancer risk factors, treatment, and survival outcomes as per the European Society for Medical Oncology (ESMO) - European Society of Gynaecological Oncology (ESGO) - European Society for Radiotherapy and Oncology (ESTRO) risk groups and International Federation of Gynecology and Obstetrics (FIGO) staging: An experience from developing world.
Gupta N; Pandey A; Dimri K; Sehgal A; Bhagat R; Suraj ; Gill G
J Cancer Res Ther; 2023; 19(3):701-707. PubMed ID: 37470597
[TBL] [Abstract][Full Text] [Related]
10. [Primary management of endometrial carcinoma. Joint recommendations of the French society of gynecologic oncology (SFOG) and of the French college of obstetricians and gynecologists (CNGOF)].
Querleu D; Darai E; Lecuru F; Rafii A; Chereau E; Collinet P; Crochet P; Marret H; Mery E; Thomas L; Villefranque V; Floquet A; Planchamp F
Gynecol Obstet Fertil Senol; 2017 Dec; 45(12):715-725. PubMed ID: 29132772
[TBL] [Abstract][Full Text] [Related]
11. Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer.
Daix M; Angeles MA; Migliorelli F; Kakkos A; Martinez Gomez C; Delbecque K; Mery E; Tock S; Gabiache E; Decuypere M; Goffin F; Martinez A; Ferron G; Kridelka F
J Gynecol Oncol; 2021 Jul; 32(4):e48. PubMed ID: 33908709
[TBL] [Abstract][Full Text] [Related]
12. [Clinical trials and perspectives of radiotherapy for uterine endometrial cancers].
Chargari C; Maroun P; Lazarescu I; Haie-Meder C
Bull Cancer; 2017 Dec; 104(12):1039-1045. PubMed ID: 29100604
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer.
Vrede SW; van Weelden WJ; Visser NCM; Bulten J; van der Putten LJM; van de Vijver K; Santacana M; Colas E; Gil-Moreno A; Moiola CP; Mancebo G; Krakstad C; Trovik J; Haldorsen IS; Huvila J; Koskas M; Weinberger V; Bednarikova M; Hausnerova J; van der Wurff AA; Matias-Guiu X; Amant F; ; Snijders MPLM; Küsters-Vandevelde HVN; Reijnen C; Pijnenborg JMA
Gynecol Oncol; 2021 Jun; 161(3):787-794. PubMed ID: 33858677
[TBL] [Abstract][Full Text] [Related]
14. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up.
Colombo N; Creutzberg C; Amant F; Bosse T; González-Martín A; Ledermann J; Marth C; Nout R; Querleu D; Mirza MR; Sessa C;
Radiother Oncol; 2015 Dec; 117(3):559-81. PubMed ID: 26683800
[TBL] [Abstract][Full Text] [Related]
15. Relevance of sentinel lymph node procedure for patients with high-risk endometrial cancer.
Naoura I; Canlorbe G; Bendifallah S; Ballester M; Daraï E
Gynecol Oncol; 2015 Jan; 136(1):60-4. PubMed ID: 25449312
[TBL] [Abstract][Full Text] [Related]
16. Issues surrounding lymphadenectomy in the management of endometrial cancer.
Bernardini MQ; Murphy JK
J Surg Oncol; 2009 Mar; 99(4):232-41. PubMed ID: 19072933
[TBL] [Abstract][Full Text] [Related]
17. Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: Results of a retrospective multicenter study.
Raimond E; Ballester M; Hudry D; Bendifallah S; Daraï E; Graesslin O; Coutant C
Gynecol Oncol; 2014 Jun; 133(3):506-11. PubMed ID: 24642092
[TBL] [Abstract][Full Text] [Related]
18. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.
Colombo N; Creutzberg C; Amant F; Bosse T; González-Martín A; Ledermann J; Marth C; Nout R; Querleu D; Mirza MR; Sessa C;
Int J Gynecol Cancer; 2016 Jan; 26(1):2-30. PubMed ID: 26645990
[TBL] [Abstract][Full Text] [Related]
19. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.
Colombo N; Creutzberg C; Amant F; Bosse T; González-Martín A; Ledermann J; Marth C; Nout R; Querleu D; Mirza MR; Sessa C;
Ann Oncol; 2016 Jan; 27(1):16-41. PubMed ID: 26634381
[TBL] [Abstract][Full Text] [Related]
20. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).
Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Daraï E
Lancet Oncol; 2011 May; 12(5):469-76. PubMed ID: 21489874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
